Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
Kazumoto Iijima(Kobe Children's Hospital), Yasuo Ohashi(Chuo University), Hidefumi Nakamura(National Center For Child Health and Development), Kenichiro Miura(Japanese Society for Dialysis Therapy), Ryojiro Tanaka(Kobe Children's Hospital), Koichi Nakanishi(University of the Ryukyus), Rintaro Mori(National Center For Child Health and Development), Hiroshi Kaito(Kobe University), Shori Takahashi(Surugadai Nihon University Hospital), Shuichi Ito(Yokohama City University), Kunihiko Aya(Okayama University), Kenji Ishikura(Kitasato University), Nao Tuchida(National Center For Child Health and Development), Koichi Kamei(National Center For Child Health and Development), Yoshiyuki Ohtomo(Juntendo University Nerima Hospital), Mayumi Sako(National Center For Child Health and Development), Kandai Nozu(Kobe Children's Hospital)
Cited by 450
Related Papers
Use of the Robson classification to assess caesarean section trends in 21 countries: a secondary analysis of two WHO multicountry surveys
|The Lancet Global Health|2015|1k
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
|Journal of Clinical Oncology|2013|632
Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels
|Pediatric Research|2013|498
A global reference for fetal-weight and birthweight percentiles
|The Lancet|2011|476
Method of Delivery and Pregnancy Outcomes in Asia
|Obstetric Anesthesia Digest|2011|285